{"id":123440,"date":"2021-06-05T04:22:18","date_gmt":"2021-06-05T11:22:18","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/06\/the-fda-has-approved-an-obesity-drug-that-helped-some-people-drop-weight"},"modified":"2021-06-05T04:22:18","modified_gmt":"2021-06-05T11:22:18","slug":"the-fda-has-approved-an-obesity-drug-that-helped-some-people-drop-weight","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/06\/the-fda-has-approved-an-obesity-drug-that-helped-some-people-drop-weight","title":{"rendered":"The FDA Has Approved An Obesity Drug That Helped Some People Drop Weight"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/the-fda-has-approved-an-obesity-drug-that-helped-some-people-drop-weight3.jpg\"><\/a><\/p>\n<p>Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S.<\/p>\n<p>The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk\u2019s diabetes drug semaglutide, for long-term weight management.<\/p>\n<p>In company-funded studies, participants taking Wegovy had average weight loss of 15%, about 34 pounds (15.3 kilograms). Participants lost weight steadily for 16 months before plateauing. In a comparison group getting dummy shots, the average weight loss was about 2.5%, or just under 6 pounds.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S. The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk\u2019s diabetes drug semaglutide, for long-term weight management. In company-funded studies, participants taking Wegovy had average weight loss of 15%, about [\u2026]<\/p>\n","protected":false},"author":413,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-123440","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/123440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/413"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=123440"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/123440\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=123440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=123440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=123440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}